Literature DB >> 20858431

Phosphorylation of caldesmon at sites between residues 627 and 642 attenuates inhibitory activity and contributes to a reduction in Ca2+-calmodulin affinity.

Svetlana S Hamden1, Mechthild M Schroeter, Joseph M Chalovich.   

Abstract

Caldesmon is an actin- and myosin-binding protein found in smooth muscle that inhibits actin activation of myosin ATPase activity. The activity of caldesmon is controlled by phosphorylation and by binding to Ca(2+)-calmodulin. We investigated the effects of phosphorylation by p(21)-activated kinase 3 (PAK) and calmodulin on the 22 kDa C-terminal fragment of caldesmon (CaD22). We substituted the major PAK sites, Ser-672 and Ser-702, with either alanine or aspartic acid to mimic nonphosphorylated and constitutively phosphorylated states of caldesmon, respectively. The aspartic acid mutation of CaD22 weakened Ca(2+)-calmodulin binding but had no effect on inhibition of ATPase activity. Phosphorylation of the aspartic acid mutant with PAK resulted in the slow phosphorylation of Thr-627, Ser-631, Ser-635, and Ser-642. Phosphorylation at these sites weakened Ca(2+)-calmodulin binding further and reduced the inhibitory activity of CaD22 in the absence of Ca(2+)-calmodulin. Phosphorylation of these sites of the alanine mutant of CaD22 had no effect on Ca(2+)-calmodulin binding but did reduce inhibition of ATPase activity. Thus, the region between residues 627 and 642 may contribute to the overall regulation of caldesmon's activity.
Copyright © 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858431      PMCID: PMC2940999          DOI: 10.1016/j.bpj.2010.07.018

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  35 in total

1.  Phosphorylation of caldesmon by p21-activated kinase. Implications for the Ca(2+) sensitivity of smooth muscle contraction.

Authors:  D B Foster; L H Shen; J Kelly; P Thibault; J E Van Eyk; A S Mak
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

2.  A model for the myosin molecule.

Authors:  W W KIELLEY; W F HARRINGTON
Journal:  Biochim Biophys Acta       Date:  1960-07-15

Review 3.  Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems.

Authors:  K Sobue; J R Sellers
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

4.  Fesselin binds to actin and myosin and inhibits actin-activated ATPase activity.

Authors:  Mechthild M Schroeter; Joseph M Chalovich
Journal:  J Muscle Res Cell Motil       Date:  2005-09-23       Impact factor: 2.698

5.  Different molecular mechanisms for Rho family GTPase-dependent, Ca2+-independent contraction of smooth muscle.

Authors:  J E Van Eyk; D K Arrell; D B Foster; J D Strauss; T Y Heinonen; E Furmaniak-Kazmierczak; G P Côté; A S Mak
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

6.  Phosphorylation of smooth muscle caldesmon by calmodulin-dependent protein kinase II. Identification of the phosphorylation sites.

Authors:  M Ikebe; S Reardon
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

7.  Mapping of contact sites in the caldesmon-calmodulin complex.

Authors:  M V Medvedeva; E A Kolobova; P A Huber; I D Fraser; S B Marston; N B Gusev
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

8.  Inhibition of actomyosin ATPase activity by troponin-tropomyosin without blocking the binding of myosin to actin.

Authors:  J M Chalovich; E Eisenberg
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

9.  The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin.

Authors:  S P Robertson; J D Johnson; M J Holroyde; E G Kranias; J D Potter; R J Solaro
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

10.  Quantitative endoproteinase GluC footprinting of cooperative Ca2+ binding to calmodulin: proteolytic susceptibility of E31 and E87 indicates interdomain interactions.

Authors:  S Pedigo; M A Shea
Journal:  Biochemistry       Date:  1995-01-31       Impact factor: 3.162

View more
  2 in total

Review 1.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

2.  Effect of l-caldesmon on osteoclastogenesis in RANKL-induced RAW264.7 cells.

Authors:  Ying-Ming Liou; Chu-Lung Chan; Renjian Huang; Chih-Lueh A Wang
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.